Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

The receptor tyrosine kinases (RTKs) are key drivers of cancer progression and targets for drug therapy. A major challenge in anti-RTK treatment is the dependence of drug effectiveness on co-expression of multiple RTKs which defines resistance to single drug therapy. Reprogramming of the RTK network...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Alexey Goltsov, Yusuf Deeni, Hilal S. Khalil, Tero Soininen, Stylianos Kyriakidis, Huizhong Hu, Simon P. Langdon, David J. Harrison, James Bown
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2014-06-01
Colecção:Cells
Assuntos:
HER2
HER3
trastuzumab
pertuzumab
combination cancer therapy
signalling reprogramming
Acesso em linha:http://www.mdpi.com/2073-4409/3/2/563
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados